Literature DB >> 22462122

Splenic marginal zone lymphoma masquerading as cirrhotic hypersplenism for seven years.

John Alfred Carr1.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22462122      PMCID： PMC3299233          DOI： 10.1155/2012/252184

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN： 0835-7900            Impact factor:   3.522


× No keyword cloud information.
  18 in total

1.  Splenic marginal zone lymphoma in a patient with chronic hepatitis B.

Authors:  Leonidas Christou; Georgios Kalambokis; Maria Bai; Sevasti Kamina; Epameinondas V Tsianos
Journal:  J Gastrointestin Liver Dis       Date:  2009-12       Impact factor: 2.008

2.  Splenectomy with chemotherapy vs surgery alone as initial treatment for splenic marginal zone lymphoma.

Authors:  Rajko Milosevic; Milena Todorovic; Bela Balint; Miodrag Jevtic; Miodrag Krstic; Elizabeta Ristanovic; Nebojsa Antonijevic; Mirjana Pavlovic; Maja Perunicic; Milan Petrovic; Biljana Mihaljevic
Journal:  World J Gastroenterol       Date:  2009-08-28       Impact factor: 5.742

3.  Surgical indications in idiopathic splenomegaly.

Authors:  John Alfred Carr; Muhammad Shurafa; Vic Velanovich
Journal:  Arch Surg       Date:  2002-01

4.  Marginal zone lymphomas: management of nodal, splenic, and MALT NHL.

Authors:  Brad Kahl; David Yang
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2008

5.  Regression of advanced non-splenic marginal zone lymphoma after treatment of hepatitis C virus infection.

Authors:  Jakub Svoboda; Charalambos Andreadis; Lisa H Downs; Wallace T Miller; Donald E Tsai; Stephen J Schuster
Journal:  Leuk Lymphoma       Date:  2005-09

6.  Emu-BCL10 mice exhibit constitutive activation of both canonical and noncanonical NF-kappaB pathways generating marginal zone (MZ) B-cell expansion as a precursor to splenic MZ lymphoma.

Authors:  Zhaoyang Li; Hongsheng Wang; Liquan Xue; Dong-Mi Shin; Derry Roopenian; Wu Xu; Chen-Feng Qi; Mark Y Sangster; Carlos J Orihuela; Elaine Tuomanen; Jerold E Rehg; Xiaoli Cui; Quangeng Zhang; Herbert C Morse; Stephan W Morris
Journal:  Blood       Date:  2009-08-20       Impact factor: 22.113

7.  A phase 2 study of concurrent fludarabine and rituximab for the treatment of marginal zone lymphomas.

Authors:  Jennifer R Brown; Jonathan W Friedberg; Yang Feng; Sarah Scofield; Kimberly Phillips; Paola Dal Cin; Robin Joyce; Ronald W Takvorian; David C Fisher; Richard I Fisher; Jane Liesveld; Diana Marquis; Donna Neuberg; Arnold S Freedman
Journal:  Br J Haematol       Date:  2009-03-30       Impact factor: 6.998

Review 8.  Splenic marginal zone lymphoma with and without villous lymphocytes.

Authors:  Estella Matutes
Journal:  Curr Treat Options Oncol       Date:  2007-04

9.  Complete remission of splenic marginal zone lymphoma after an acute flare-up of hepatitis B in a hepatitis B virus carrier.

Authors:  Katsuya Fujimoto; Tomoyuki Endo; Mitsufumi Nishio; Masato Obara; Keisuke Yamaguchi; Yukari Takeda; Hideki Goto; Ikumi Kasahara; Norihiro Sato; Takao Koike
Journal:  Int J Hematol       Date:  2009-10-06       Impact factor: 2.490

10.  Non-gastric marginal zone B cell lymphoma: clinicopathologic features and treatment results.

Authors:  Harinder Gill; Chor-Sang Chim; Wing-Yan Au; Florence Loong; Eric Tse; Anskar Y H Leung; Yok-Lam Kwong
Journal:  Ann Hematol       Date:  2011-04-08       Impact factor: 3.673
View more
  1 in total

1.  Analysis of feasibility, safety and effectiveness of ultrasound-guided percutaneous microwave ablation of splenic neoplasm.

Authors:  Na Luo; Yan Wang; Zhe Geng; Xiantao Qin
Journal:  Oncol Lett       Date:  2018-01-23       Impact factor: 2.967
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.